89bio Inc Stock Performance
| ETNB Stock | USD 9.64 0.91 10.42% |
On a scale of 0 to 100, 89bio holds a performance score of 3. The firm shows a Beta (market volatility) of 0.9, which signifies possible diversification benefits within a given portfolio. 89bio returns are very sensitive to returns on the market. As the market goes up or down, 89bio is expected to follow. Please check 89bio's sortino ratio, semi variance, and the relationship between the information ratio and value at risk , to make a quick decision on whether 89bio's price patterns will revert.
Risk-Adjusted Performance
3 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in 89bio Inc are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat conflicting basic indicators, 89bio sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (3.11) | Five Day Return 22.44 | Year To Date Return 9.4 | Ten Year Return (58.03) | All Time Return (58.03) |
1 | RA CAPITAL MANAGEMENT, L.P. Increases Stake in 89bio Inc - GuruFocus.com | 11/19/2024 |
2 | Acquisition by Rohan Palekar of 10000 shares of 89bio at 8.35 subject to Rule 16b-3 | 11/22/2024 |
3 | Disposition of 6124 shares by Ryan Martins of 89bio at 11.53 subject to Rule 16b-3 | 12/02/2024 |
4 | 89bio, Inc. Shares Bought by Janus Henderson Group PLC | 12/05/2024 |
5 | Acquisition by Rohan Palekar of 5000 shares of 89bio at 7.89 subject to Rule 16b-3 | 12/06/2024 |
6 | CEO Rohan Palekar Increases Stake in 89bio Inc with Recent Share Purchase | 12/10/2024 |
7 | Disposition of 95000 shares by Ryan Martins of 89bio subject to Rule 16b-3 | 12/12/2024 |
8 | 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635 | 12/19/2024 |
9 | Jane Street Group LLC Has 1.03 Million Stock Holdings in 89bio, Inc. - MarketBeat | 12/31/2024 |
10 | Disposition of 3821 shares by Mansbach Harry H of 89bio at 16.61 subject to Rule 16b-3 | 01/08/2025 |
11 | Empery Asset Management, LPs Strategic Acquisition in Critical Metals Corp | 01/10/2025 |
12 | Disposition of 10963 shares by Le-nguyen Quoc of 89bio at 6.49 subject to Rule 16b-3 | 01/15/2025 |
13 | 89bio Stock Price Down 4 percent Time to Sell | 01/16/2025 |
14 | Acquisition by Mcwherter Charles of 5000 shares of 89bio at 6.55 subject to Rule 16b-3 | 01/21/2025 |
15 | Acquisition by Mcwherter Charles of 10000 shares of 89bio at 6.71 subject to Rule 16b-3 | 01/22/2025 |
16 | Disposition of 1014 shares by Mansbach Harry H of 89bio at 15.46 subject to Rule 16b-3 | 01/28/2025 |
17 | MASH momentum prompts 250 million raise for 89bio - The Pharma Letter | 01/29/2025 |
| Begin Period Cash Flow | 55.3 M | |
| Free Cash Flow | -129.2 M |
89bio |
89bio Relative Risk vs. Return Landscape
If you would invest 914.00 in 89bio Inc on November 1, 2024 and sell it today you would earn a total of 50.00 from holding 89bio Inc or generate 5.47% return on investment over 90 days. 89bio Inc is currently generating 0.2352% in daily expected returns and assumes 5.6009% risk (volatility on return distribution) over the 90 days horizon. In different words, 49% of stocks are less volatile than 89bio, and 96% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
89bio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for 89bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as 89bio Inc, and traders can use it to determine the average amount a 89bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.042
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ETNB | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.6 actual daily | 49 51% of assets are more volatile |
Expected Return
| 0.24 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average 89bio is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of 89bio by adding it to a well-diversified portfolio.
89bio Fundamentals Growth
89bio Stock prices reflect investors' perceptions of the future prospects and financial health of 89bio, and 89bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on 89bio Stock performance.
| Return On Equity | -0.73 | ||||
| Return On Asset | -0.41 | ||||
| Current Valuation | 673.21 M | ||||
| Shares Outstanding | 117.58 M | ||||
| Price To Earning | (1.04) X | ||||
| Price To Book | 2.80 X | ||||
| EBITDA | (134.46 M) | ||||
| Net Income | (142.19 M) | ||||
| Cash And Equivalents | 193.34 M | ||||
| Cash Per Share | 4.16 X | ||||
| Total Debt | 27.11 M | ||||
| Debt To Equity | 0.13 % | ||||
| Current Ratio | 5.81 X | ||||
| Book Value Per Share | 3.56 X | ||||
| Cash Flow From Operations | (129.19 M) | ||||
| Earnings Per Share | (2.96) X | ||||
| Market Capitalization | 1.03 B | ||||
| Total Asset | 596.27 M | ||||
| Retained Earnings | (457.43 M) | ||||
| Working Capital | 563.92 M | ||||
| Current Asset | 10.12 M | ||||
| Current Liabilities | 3.89 M | ||||
About 89bio Performance
By analyzing 89bio's fundamental ratios, stakeholders can gain valuable insights into 89bio's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if 89bio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if 89bio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.21) | (0.23) | |
| Return On Capital Employed | (0.24) | (0.25) | |
| Return On Assets | (0.21) | (0.23) | |
| Return On Equity | (0.30) | (0.32) |
Things to note about 89bio Inc performance evaluation
Checking the ongoing alerts about 89bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for 89bio Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| 89bio Inc had very high historical volatility over the last 90 days | |
| Net Loss for the year was (142.19 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| 89bio Inc currently holds about 193.34 M in cash with (129.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.16. | |
| 89bio Inc has a frail financial position based on the latest SEC disclosures | |
| Over 97.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: MASH momentum prompts 250 million raise for 89bio - The Pharma Letter |
- Analyzing 89bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether 89bio's stock is overvalued or undervalued compared to its peers.
- Examining 89bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating 89bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of 89bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of 89bio's stock. These opinions can provide insight into 89bio's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for 89bio Stock analysis
When running 89bio's price analysis, check to measure 89bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 89bio is operating at the current time. Most of 89bio's value examination focuses on studying past and present price action to predict the probability of 89bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 89bio's price. Additionally, you may evaluate how the addition of 89bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |